Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Venture Capital

NEA Leads $44M Series B For Annexon Biosciences

by dc.citybizlist.com posted 2years ago 810 views
Annexon Biosciences, a biopharmaceutical company pioneering the development of classical complement pathway

In this article